Arbutus Biopharma (ABUS) Net Income towards Common Stockholders (QoQ) (2013 - 2026)
Arbutus Biopharma (ABUS) Net Income towards Common Stockholders (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Arbutus Biopharma | 862.27 Mn | 767.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,515.86% |
| Dec 31, 2025 | 35.73% |
| Sep 30, 2025 | -408.95% |
| Jun 30, 2025 | 110.20% |
| Mar 31, 2025 | -96.26% |
| Dec 31, 2024 | 36.62% |
| Sep 30, 2024 | 0.65% |
| Jun 30, 2024 | -10.37% |
| Mar 31, 2024 | 6.87% |
| Dec 31, 2023 | 3.94% |
| Sep 30, 2023 | -17.61% |
| Jun 30, 2023 | -4.62% |
| Mar 31, 2023 | 25.50% |
| Dec 31, 2022 | -24.85% |
| Sep 30, 2022 | -23.78% |
| Jun 30, 2022 | 9.98% |
| Mar 31, 2022 | 28.00% |
| Dec 31, 2021 | 9.69% |
| Sep 30, 2021 | -7.03% |
| Jun 30, 2021 | -15.62% |